Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Muriel Finkel"'
Autor:
Jose Nativi-Nicolau, Nitasha Sarswat, Johana Fajardo, Muriel Finkel, Younos Abdulsattar, Adam Castaño, Lori Klein, Alexandra Haddad-Angulo
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 15 (2021)
Background: Because transthyretin amyloid cardiomyopathy (ATTR-CM) poses unique diagnostic and therapeutic challenges, referral of patients with known or suspected disease to specialized amyloidosis centers is recommended. These centers have develope
Externí odkaz:
https://doaj.org/article/d8adbbac31b34ec2851ef9883e6b408d
Publikováno v:
Quality of Life Research. 32:1807-1817
Autor:
Morie A. Gertz, Rafat Abonour, Sarah N. Gibbs, Muriel Finkel, Heather Landau, Suzanne Lentzsch, Grace Lin, Anuj Mahindra, Tiffany P. Quock, Cara A. Rosenbaum, Michael Rosenzweig, Surbhi Sidana, Sascha A. Tuchman, Ronald Witteles, Irina Yermilov, Michael S. Broder
Publikováno v:
Blood. 140:13129-13131
Autor:
Chafic Karam, Catherine Summers, Colleen Moffitt, Madeline P Merkel, Fran M Kochman, Laure S Weijers, Marieke Schurer, Nicola Mason, Muriel Finkel, Mazen Hanna
Publikováno v:
Journal of Cardiac Failure. 29:704
Autor:
Anita D'Souza, Judith Myers, Rachel Cusatis, Angela Dispenzieri, Muriel Finkel, Julie Panepinto, Kathryn E Flynn
Background Light chain (AL) amyloidosis is a plasma cell neoplasm associated with high early mortality and severe morbidity that can cause severe disability. We explored the impact of AL amyloidosis on symptoms and well-being from the perspectives of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edd00fe37b4d2b04cf1bab7e37ea3e0e
https://doi.org/10.21203/rs.3.rs-272559/v1
https://doi.org/10.21203/rs.3.rs-272559/v1
Publikováno v:
Journal of the American College of Cardiology. 79:458
Autor:
Spencer D. Guthrie, Tiffany P. Quock, Martha S. Bayliss, Michelle K. White, Kristen L. McCausland, Isabelle Lousada, Muriel Finkel
Publikováno v:
The Patient
Background Light chain (AL) amyloidosis is a rare, complex disease associated with significant morbidity and mortality. Delays in diagnosis are common and may have detrimental consequences on patients’ prognosis. Too little is known regarding the p
Autor:
Johana Fajardo, Muriel Finkel, Younos Abdulsattar, Adam Castaño, Nitasha Sarswat, Jose Nativi-Nicolau, Alexandra Haddad, Lori Klein
Publikováno v:
Journal of Cardiac Failure. 26:S131
Introduction Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that is underdiagnosed and frequently recognized at a late stage. ATTR-CM poses unique diagnostic and therapeutic challenges that often requi
Autor:
Mary O'Donnell, Younos Abdulsattar, Jose Nativi-Nicolau, Marianna Bruno, Adam Castaño, Isabelle Lousada, Muriel Finkel
Publikováno v:
Journal of Cardiac Failure. 25:S90
Introduction Cardiac amyloidosis (CA) can be difficult to diagnose, with a prolonged and often complex patient journey. The most common forms of CA include light-chain (AL) amyloidosis and transthyretin amyloidosis (hereditary or wild-type). The intr
Autor:
Muriel Finkel
Publikováno v:
Current Clinical Pathology ISBN: 9783319192932
Amyloid and Related Disorders ISBN: 9781607613886
Amyloid and Related Disorders ISBN: 9781607613886
The information and views presented in this chapter are derived from e-mail and personal contacts with members of the Amyloidosis Support Groups, Inc. (ASG), an association of patient support groups from the United States, Canada, and Mexico. Despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537ce5cc5abf63432aa25b50c0eb848d
https://doi.org/10.1007/978-3-319-19294-9_40
https://doi.org/10.1007/978-3-319-19294-9_40